ClinVar Miner

Submissions for variant NM_000348.4(SRD5A2):c.586G>C (p.Gly196Arg) (rs121434250)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Institute of Reproductive and Stem Cell Engineering,Central South University RCV000660891 SCV000680460 pathogenic 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency 2018-02-01 criteria provided, single submitter clinical testing The novel mutation p.G196R and a known mutation p.Q6X were identified in a patient who had perineal hypospadias. Although in vitro studies have not been performed to investigate the functional impact of the p.G196R mutation, several lines of evidence suggest that it is a disease-causing mutation. Firstly, codon 196 is highly conserved. Secondly, in silico analysis by the PolyPhen-2 and PROVEAN software predicted p.G196R to be a "probably damaging" and "deleterious" mutation, respectively. Finally, in this same codon, pathogenic mutations G196S and G196D have been identified previously. Experiments have shown that the G196S mutation could reduce the overall enzyme activity and increase the optimum pH slightly. According to the interpretation of the American College of Medical Genetics and Genomics (ACMG) guidelines, the missense mutation p.G196R was likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.